MUC1 and pulmonary fibrosis: This academic pursuit, supported by the aforementioned assumptions, not only seeks to deepen our understanding of pulmonary fibrosis dynamics but also to confer upon KL-6 the status of a versatile and potent biomarker with implications extending across both BAL and serum analyses.